---
document_datetime: 2025-12-02 06:17:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/agenerase.html
document_name: agenerase.html
version: success
processing_time: 0.1073645
conversion_datetime: 2025-12-24 00:18:15.882632
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Agenerase

[RSS](/en/individual-human-medicine.xml/66731)

##### Withdrawn

This medicine's authorisation has been withdrawn

amprenavir Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 20 October 2000 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Agenerase (amprenavir). Agenerase had been approved in combination with other antiretroviral agents for the treatment of protease inhibitor (PI) experienced HIV-1 infected adults and children above the age of 4 years.

The marketing authorisation holder (MAH) responsible for Agenerase was Glaxo Group Ltd. The European Commission was notified by letter dated 17 December 2009 of the MAH's decision to voluntarily withdraw the marketing authorisation for Agenerase for commercial reasons. Agenerase had not been marketed anywhere in the European Union since the end of 2008.

On 29 April 2010 the European Commission issued a decision to withdraw the marketing authorisation for Agenerase. Pursuant to this decision the European Public Assessment Report for Agenerase is updated to reflect that the marketing authorisation is no longer valid.

Agenerase : EPAR - Summary for the public

English (EN) (263.12 KB - PDF)

**First published:** 28/11/2008

**Last updated:** 21/06/2011

[View](/en/documents/overview/agenerase-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-763)

български (BG) (474.02 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/bg/documents/overview/agenerase-epar-summary-public_bg.pdf)

español (ES) (265.61 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/es/documents/overview/agenerase-epar-summary-public_es.pdf)

čeština (CS) (411.57 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/cs/documents/overview/agenerase-epar-summary-public_cs.pdf)

dansk (DA) (265.29 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/da/documents/overview/agenerase-epar-summary-public_da.pdf)

Deutsch (DE) (266.72 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/de/documents/overview/agenerase-epar-summary-public_de.pdf)

eesti keel (ET) (263.24 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/et/documents/overview/agenerase-epar-summary-public_et.pdf)

ελληνικά (EL) (470.71 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/el/documents/overview/agenerase-epar-summary-public_el.pdf)

français (FR) (266.53 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/fr/documents/overview/agenerase-epar-summary-public_fr.pdf)

italiano (IT) (264.07 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/it/documents/overview/agenerase-epar-summary-public_it.pdf)

latviešu valoda (LV) (417.91 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/lv/documents/overview/agenerase-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (380.43 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/lt/documents/overview/agenerase-epar-summary-public_lt.pdf)

magyar (HU) (400.35 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/hu/documents/overview/agenerase-epar-summary-public_hu.pdf)

Malti (MT) (417.62 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/mt/documents/overview/agenerase-epar-summary-public_mt.pdf)

Nederlands (NL) (265.61 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/nl/documents/overview/agenerase-epar-summary-public_nl.pdf)

polski (PL) (419.97 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/pl/documents/overview/agenerase-epar-summary-public_pl.pdf)

português (PT) (265.93 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/pt/documents/overview/agenerase-epar-summary-public_pt.pdf)

română (RO) (373.19 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/ro/documents/overview/agenerase-epar-summary-public_ro.pdf)

slovenčina (SK) (407.83 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/sk/documents/overview/agenerase-epar-summary-public_sk.pdf)

slovenščina (SL) (364.9 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/sl/documents/overview/agenerase-epar-summary-public_sl.pdf)

Suomi (FI) (264.79 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/fi/documents/overview/agenerase-epar-summary-public_fi.pdf)

svenska (SV) (264.98 KB - PDF)

**First published:**

28/11/2008

**Last updated:**

21/06/2011

[View](/sv/documents/overview/agenerase-epar-summary-public_sv.pdf)

## Product information

Agenerase : EPAR - Product Information

English (EN) (634.28 KB - PDF)

**First published:** 16/12/2009

**Last updated:** 21/06/2011

[View](/en/documents/product-information/agenerase-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-830)

български (BG) (4.1 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/bg/documents/product-information/agenerase-epar-product-information_bg.pdf)

español (ES) (683.36 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/es/documents/product-information/agenerase-epar-product-information_es.pdf)

čeština (CS) (2.75 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/cs/documents/product-information/agenerase-epar-product-information_cs.pdf)

dansk (DA) (644.58 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/da/documents/product-information/agenerase-epar-product-information_da.pdf)

Deutsch (DE) (707.8 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/de/documents/product-information/agenerase-epar-product-information_de.pdf)

eesti keel (ET) (654.32 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/et/documents/product-information/agenerase-epar-product-information_et.pdf)

ελληνικά (EL) (1.34 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/el/documents/product-information/agenerase-epar-product-information_el.pdf)

français (FR) (796.57 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/fr/documents/product-information/agenerase-epar-product-information_fr.pdf)

italiano (IT) (694.68 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/it/documents/product-information/agenerase-epar-product-information_it.pdf)

latviešu valoda (LV) (1.06 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/lv/documents/product-information/agenerase-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.03 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/lt/documents/product-information/agenerase-epar-product-information_lt.pdf)

magyar (HU) (1.02 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/hu/documents/product-information/agenerase-epar-product-information_hu.pdf)

Malti (MT) (1.16 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/mt/documents/product-information/agenerase-epar-product-information_mt.pdf)

Nederlands (NL) (772 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/nl/documents/product-information/agenerase-epar-product-information_nl.pdf)

polski (PL) (1.08 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/pl/documents/product-information/agenerase-epar-product-information_pl.pdf)

português (PT) (805.04 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/pt/documents/product-information/agenerase-epar-product-information_pt.pdf)

română (RO) (968.02 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/ro/documents/product-information/agenerase-epar-product-information_ro.pdf)

slovenčina (SK) (1.06 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/sk/documents/product-information/agenerase-epar-product-information_sk.pdf)

slovenščina (SL) (938.89 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/sl/documents/product-information/agenerase-epar-product-information_sl.pdf)

Suomi (FI) (772.2 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/fi/documents/product-information/agenerase-epar-product-information_fi.pdf)

svenska (SV) (665.61 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

21/06/2011

[View](/sv/documents/product-information/agenerase-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0044 29/04/2011

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Agenerase : EPAR - All Authorised presentations

English (EN) (271.95 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 21/06/2011

[View](/en/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_en.pdf)

[Other languages (20)](#file-language-dropdown-611)

български (BG) (307.13 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/bg/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_bg.pdf)

español (ES) (274.99 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/es/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_es.pdf)

čeština (CS) (306.54 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/cs/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (278.54 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/da/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (277.17 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/de/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (273.13 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/et/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (307.21 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/el/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_el.pdf)

français (FR) (275.55 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/fr/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (265.98 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/it/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (298.57 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/lv/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (285.94 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/lt/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (305.9 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/hu/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (266.72 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/nl/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_nl.pdf)

polski (PL) (308.29 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/pl/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_pl.pdf)

português (PT) (274.18 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/pt/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_pt.pdf)

română (RO) (284.16 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/ro/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (307.05 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/sk/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (303.34 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/sl/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (272.25 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/fi/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (275.67 KB - PDF)

**First published:**

21/10/2005

**Last updated:**

21/06/2011

[View](/sv/documents/all-authorised-presentations/agenerase-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Agenerase Active substance amprenavir International non-proprietary name (INN) or common name amprenavir Therapeutic area (MeSH) HIV Infections Anatomical therapeutic chemical (ATC) code J05AE05

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Agenerase, in combination with other antiretroviral agents, is indicated for the treatment of protease inhibitor (PI) experienced HIV-1 infected adults and children above the age of 4 years. Agenerase capsules should normally be administered with low dose ritonavir as a pharmacokinetic enhancer of amprenavir (see sections 4.2 and 4.5). The choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1).

## Authorisation details

EMA product number EMEA/H/C/000264 Marketing authorisation holder

Glaxo Group Ltd.

Greenford Road Greenford, Middx UB6 0NN United Kingdom

Marketing authorisation issued 20/10/2000 Withdrawal of marketing authorisation 29/04/2010 Revision 18

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Agenerase : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (312.2 KB - PDF)

**First published:** 16/12/2009

**Last updated:** 21/06/2011

[View](/en/documents/procedural-steps-after/agenerase-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Agenerase : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (265.34 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 21/06/2011

[View](/en/documents/steps-after-cutoff/agenerase-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Agenerase : EPAR - Procedural steps taken before authorisation

English (EN) (250.16 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 21/06/2011

[View](/en/documents/procedural-steps/agenerase-epar-procedural-steps-taken-authorisation_en.pdf)

Agenerase : EPAR - Scientific Discussion

English (EN) (663.33 KB - PDF)

**First published:** 21/10/2005

**Last updated:** 21/06/2011

[View](/en/documents/scientific-discussion/agenerase-epar-scientific-discussion_en.pdf)

**This page was last updated on** 21/06/2011

## Share this page

[Back to top](#main-content)